BioPharmSignal logoBioPharmSignal

Biotech News

Veradigm Brings Patient Voice to Healthcare Research with New Real-World Data Survey Solution

Veradigm (MDRX)VeradigmCompany update

CHICAGO --(BUSINESS WIRE)--Feb. 13, 2026-- Veradigm (OTCMKTS:MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, today announced a new patient‑reported outcomes (PRO) survey capability that brings the patient voice directly into real‑world evidence

Related news

MDRXVeradigm2026-01-15 21:01 EST

Veradigm and Meperia Launch Industry-First 8-Way Match EDI Platform to Strengthen Healthcare Supply Chain Integrity

MDRXVeradigm2026-05-06 12:01 EST

Veradigm Survey: Independent Practices Rely on Technology to Stay Independent

View all latest news

Veradigm

Veradigm is a healthcare information and analytics company focused on software, data, and workflow tools for providers and life-sciences customers. Its business is more about information infrastructure than therapeutic innovation.

Recent company news

MDRXVeradigm2026-08-17 12:01 EST

Veradigm to Participate in Two Upcoming Investor Conferences

MDRXVeradigm2026-05-26 20:10 EST

Veradigm Files 2023 and 2024 Form 10-K

MDRXVeradigm2026-05-26 12:01 EST

Veradigm to Release Business Update May 26th and Host Investor Call May 27th

MDRXVeradigm2026-05-06 20:01 EST

Veradigm Launches Health Network Architecture to Level the Playing Field for Independent Practices

MDRXVeradigm2026-05-06 12:01 EST

Veradigm Survey: Independent Practices Rely on Technology to Stay Independent

Stock data

Close
4.97 USD
Market cap
—
Exchange
NASDAQ
Sector
Biopharma
Location
United States